Globe Life (NYSE:GL) Releases FY 2021 Earnings Guidance


Share on StockTwits

Globe Life (NYSE:GL) issued an update on its FY 2021 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of 7.210-7.510 for the period, compared to the Thomson Reuters consensus estimate of $7.340. The company issued revenue guidance of -.

GL stock traded up $0.70 during mid-day trading on Tuesday, reaching $104.03. The company had a trading volume of 3,170 shares, compared to its average volume of 431,581. The company has a debt-to-equity ratio of 0.20, a current ratio of 0.07 and a quick ratio of 0.07. The company has a market capitalization of $12.06 billion, a PE ratio of 15.68 and a beta of 1.13. The firm has a 50 day moving average of $100.50 and a 200 day moving average of $94.68. Globe Life has a 12 month low of $62.75 and a 12 month high of $105.58.

Globe Life (NYSE:GL) last issued its earnings results on Tuesday, April 20th. The company reported $1.53 EPS for the quarter, missing the Zacks’ consensus estimate of $1.65 by ($0.12). The company had revenue of $1.27 billion during the quarter, compared to the consensus estimate of $1.25 billion. Globe Life had a return on equity of 10.28% and a net margin of 15.38%. Globe Life’s revenue was up 11.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $1.73 earnings per share.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 30th. Stockholders of record on Monday, July 5th will be paid a dividend of $0.1975 per share. This represents a $0.79 dividend on an annualized basis and a dividend yield of 0.76%.

A number of research firms have recently issued reports on GL. JPMorgan Chase & Co. increased their price objective on shares of Globe Life from $99.00 to $103.00 and gave the company an overweight rating in a research note on Monday, April 5th. Morgan Stanley increased their price objective on shares of Globe Life from $95.00 to $100.00 and gave the company an underweight rating in a research note on Thursday, April 1st. Finally, Piper Sandler increased their price objective on shares of Globe Life from $87.00 to $95.00 and gave the company a neutral rating in a research note on Wednesday, January 6th. One analyst has rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the company. The company currently has an average rating of Hold and a consensus target price of $101.20.

In other Globe Life news, CFO Frank M. Svoboda sold 15,000 shares of the firm’s stock in a transaction on Thursday, April 29th. The shares were sold at an average price of $102.94, for a total value of $1,544,100.00. Following the completion of the transaction, the chief financial officer now owns 15,000 shares of the company’s stock, valued at $1,544,100. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, CEO Larry M. Hutchison sold 12,000 shares of the firm’s stock in a transaction on Monday, April 26th. The stock was sold at an average price of $103.22, for a total transaction of $1,238,640.00. Following the completion of the transaction, the chief executive officer now directly owns 727,112 shares of the company’s stock, valued at approximately $75,052,500.64. The disclosure for this sale can be found here. Insiders have sold 164,150 shares of company stock valued at $16,455,919 in the last three months. 3.78% of the stock is currently owned by corporate insiders.

About Globe Life

Globe Life, Inc is a holding company, which engages in the provision of individual life and supplemental health insurance products and services. It operates through the following segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments. The Life Insurance segment includes traditional and interest-sensitive whole life insurance as well as term life insurances.

Further Reading: Channel Trading

Earnings History and Estimates for Globe Life (NYSE:GL)

Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.